<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>TIZIMLI SKLERODERMIYADA O‘PKA ZARARLANISHINING KLINIKIMMUNOLOGIK JIHATLARI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Sanjarbek</mods:namePart><mods:namePart type="family">Zaripov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Nargiza</mods:namePart><mods:namePart type="family">Abduraxmanova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Tizimli sklerodermiya (TSD) — surunkali, progressiv kechuvchi autoimmun kasallik bo‘lib,biriktiruvchi to‘qimalarda fibroz jarayonlar, kichik tomirlar endoteliyasining zararlanishi va kengqamrovli immun buzilishlar bilan tavsiflanadi. Kasallikning tarqalishi umumiy populyatsiyada 100ming aholiga 7–25 ta holatni tashkil etadi. Ayniqsa, interstitsial o‘pka kasalligi va o‘pkagipertenziyasi kabi asoratlar bemorlarning erta nogironlikka chiqishiga va yuqori o‘limko‘rsatkichlariga olib keluvchi yetakchi omillardan biridir. Ushbu kasallikning ijtimoiy va iqtisodiyahamiyati ham katta bo‘lib, nogironlikning erta rivojlanishi, uzoq muddatli davolanish zarurati hamdasog‘liqni saqlash tizimiga tushadigan katta moliyaviy yuk tufayli dolzarb muammo sifatida ko‘riladi.Shuning uchun tizimli sklerodermiyada o‘pka zararlanishining klinik va immunologik xususiyatlarinio‘rganish, erta tashxis va samarali davolash usullarini ishlab chiqish muhim ilmiy-amaliy ahamiyatgaega.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-02-05</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>South Aral Region Medical Journal</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>